IRIS PubliCatt

Biolato, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.637
NA - Nord America 1.432
AS - Asia 491
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 3
Totale 3.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.427
DE - Germania 490
SE - Svezia 368
IT - Italia 255
CN - Cina 186
SG - Singapore 139
IE - Irlanda 124
UA - Ucraina 106
ID - Indonesia 75
RU - Federazione Russa 61
FR - Francia 57
GB - Regno Unito 53
FI - Finlandia 46
IN - India 43
BE - Belgio 24
TR - Turchia 18
PL - Polonia 10
HK - Hong Kong 9
CZ - Repubblica Ceca 8
IR - Iran 7
NL - Olanda 6
RO - Romania 6
CH - Svizzera 5
CI - Costa d'Avorio 5
DK - Danimarca 5
GR - Grecia 5
JP - Giappone 5
AU - Australia 4
EU - Europa 4
CA - Canada 3
ES - Italia 3
IL - Israele 2
PE - Perù 2
RE - Reunion 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BZ - Belize 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
KG - Kirghizistan 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PR - Porto Rico 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 3.579
Salva come PNG Salva come JPEG
Città #
Chandler 322
Ashburn 146
Dublin 124
Singapore 108
Jakarta 75
New York 69
Rome 68
Jacksonville 60
San Mateo 51
Milan 49
Wilmington 46
Nanjing 44
Cattolica 41
Chicago 37
Boston 36
Dearborn 35
Moscow 33
Marseille 31
Helsinki 29
Princeton 28
Brussels 24
Ann Arbor 22
Munich 22
Los Angeles 19
Nürnberg 19
Woodbridge 19
Beijing 18
Redwood City 17
Saint Petersburg 17
Augusta 15
Izmir 15
Nanchang 15
Bremen 14
Falls Church 13
Changsha 11
Seattle 11
Hebei 10
Kraków 10
Norwalk 10
Shenyang 10
Tianjin 10
Boardman 9
Fairfield 9
Kunming 8
Lawrence 8
Brno 7
Houston 7
Hong Kong 6
Lancaster 6
Leawood 6
Portland 6
Washington 6
Abidjan 5
Fremont 5
Guangzhou 5
Jiaxing 5
London 5
Nuremberg 5
Zhengzhou 5
Amsterdam 4
Athens 4
Atlanta 4
Edinburgh 4
Falkenstein 4
Jinan 4
Mountain View 4
Pune 4
San Diego 4
Santa Clara 4
University Park 4
Andover 3
Genoa 3
Hangzhou 3
Hounslow 3
Kish 3
Palermo 3
Simi Valley 3
Taizhou 3
Zurich 3
Boydton 2
Brescia 2
Buffalo 2
Cantagallo 2
Chiswick 2
Clayton 2
Como 2
Copenhagen 2
Dallas 2
Fontanelle 2
Jodhpur 2
Köln 2
Lanzhou 2
Las Vegas 2
Lima 2
Meppel 2
Monmouth Junction 2
Nardò 2
Nichelino 2
Orange 2
Orangeburg 2
Totale 1.979
Salva come PNG Salva come JPEG
Nome #
A phase II study of sunitinib in advanced hepatocellular carcinoma 204
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 180
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 154
Vanishing-recurrent benign liver lesions 113
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 110
[The treatment of hepatocellular carcinoma: an update] 105
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 105
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 97
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 91
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 90
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 89
Liver transplantation in patients with alcoholic liver disease: A retrospective study 89
Severe giant cell arteritis associated with essential thrombocythaemia. 85
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 85
A giant calcified hepatic mass 77
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 75
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 72
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 72
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 69
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 68
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 67
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 64
Acute HEV hepatitis: clinical and laboratory diagnosis 59
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 58
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy 56
Liver transplantation for drug-induced acute liver failure 56
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach 53
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 52
Fatty liver and drugs: the two sides of the same coin 51
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 50
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 49
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all 47
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 45
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review 43
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 39
Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 39
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 37
Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI 37
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 35
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 31
Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI (BMC Gastroenterology, (2021), 21, 1, (317), 10.1186/s12876-021-01878-3) 30
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 27
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 25
ORGANIZATIONAL AND ECONOMIC ISSUES RELATED TO THE INTRODUCTION OF BOCEPREVIR IN THE TREATMENT OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN ITALY 22
Clinical impact of comorbidities in an Italian NAFLD cohort 22
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 22
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 22
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 21
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 21
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 21
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 21
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series 21
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 20
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 20
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 20
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 20
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 19
Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? 19
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 19
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 18
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 17
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 16
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines 15
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 14
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 14
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 13
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 12
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 12
Starvation hepatitis and refeeding-induced hepatitis: mechanism, diagnosis, and treatment 12
Corrigendum to "Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at all" [J Hepatol 50 (2009) 1273-1277] (DOI:10.1016/j.jhep.2009.02.021) 11
Abdominal angina 9
Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature 8
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 7
Totale 3.658
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020246 0 0 0 10 33 31 53 17 14 27 38 23
2020/2021245 4 25 10 35 38 10 25 9 33 13 36 7
2021/2022406 14 23 9 49 36 16 15 69 14 17 65 79
2022/20231.075 132 110 55 144 93 159 64 94 104 33 69 18
2023/2024713 49 172 26 46 35 111 45 33 13 39 47 97
2024/2025210 30 29 126 25 0 0 0 0 0 0 0 0
Totale 3.658